Debt to Equity Ratio Chart

View Debt to Equity Ratio for PBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -0.7842
March 31, 2024 -0.8419
December 31, 2023 -0.7293
September 30, 2023 -0.7413
June 30, 2023 -0.7727
March 31, 2023 -0.6126
December 31, 2022 -0.6281
September 30, 2022 -0.648
June 30, 2022 -0.6645
March 31, 2022 -0.6593
December 31, 2021 -0.6593
September 30, 2021 -0.6792
June 30, 2021 -0.5907
March 31, 2021 -0.5933
December 31, 2020 -0.5672
September 30, 2020 -0.594
June 30, 2020 -0.5952
March 31, 2020 -0.6356
December 31, 2019 -0.6599
September 30, 2019 -0.7137
June 30, 2019 -0.7414
March 31, 2019 -0.8248
December 31, 2018 -0.817
September 30, 2018 -0.8249
June 30, 2018 -0.8275
Date Value
March 31, 2018 -0.8896
December 31, 2017 -0.9005
September 30, 2017 -0.9216
June 30, 2017 -0.739
March 31, 2017 -0.5548
December 31, 2016 -0.6575
September 30, 2016 -0.3124
June 30, 2016 -0.2104
March 31, 2016 -0.0971
December 31, 2015 -0.0538
September 30, 2015 -0.7085
June 30, 2015 -0.8214
March 31, 2015 -0.383
December 31, 2014 -0.5268
September 30, 2014 -0.6003
June 30, 2014 -0.3837
March 31, 2014 -0.1872
December 31, 2013 -0.2399
September 30, 2013 -0.3354
June 30, 2013 -0.1707
March 31, 2013 -0.292
December 31, 2012 -0.6733
September 30, 2012 -0.7076
June 30, 2012 -0.2009
March 31, 2012 -0.3242

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Agilent Technologies, Inc. 0.5363
Bio-Rad Laboratories, Inc. 0.191
Bruker Corp. 0.7663
Danaher Corp. 0.5298
Harvard Bioscience, Inc. 5.959